Survival and Mortality Predictors Among Hemodialysis Patients in a Pakistani Tertiary Care Center: A Retrospective Cohort Study

Irfan Elahi; Mehwish Mushtaq; Muhammad Anees; Shahbaz Pervaiz; Sana Kifayat; Bilal Javaid; SameeUllah Khan

doi:10.70749/ijbr.v3i5.1279

Authors

Irfan Elahi Department of Nephrology, King Edward Medical University, Lahore, Punjab, Pakistan.
Mehwish Mushtaq Metrics Research Private Limited, Pakistan.
Muhammad Anees Department of Nephrology, King Edward Medical University, Lahore, Punjab, Pakistan.
Shahbaz Pervaiz Department of Nephrology, King Edward Medical University, Lahore, Punjab, Pakistan.
Sana Kifayat Department of Nephrology, King Edward Medical University, Lahore, Punjab, Pakistan.
Bilal Javaid Department of Nephrology, Faisalabad Medical University, Faisalabad, Punjab, Pakistan.
SameeUllah Khan Department of Nephrology, Sahiwal Medical College, Sahiwal, Punjab, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i5.1279

Keywords:

Hemodialysis, Survival analysis, Cox Regression, End-stage renal disease (ESRD), Albumin, BMI, Mortality predictors, Pakistan, Maintenance Hemodialysis (MHD)

Abstract

Background: End-stage renal disease (ESRD) is a growing public health burden in low- and middle-income countries, including Pakistan, where access to maintenance hemodialysis (MHD) is expanding, but long-term survival outcomes remain underreported. This study evaluated the survival duration and clinical predictors of mortality among patients undergoing MHD at a tertiary care hospital in Pakistan. Methods: A retrospective analysis of prospectively collected data was conducted on patients receiving MHD between 2012 and 2014 at Mayo Hospital, King Edward Medical University, Lahore. Patients on dialysis for ≥3 months were included. Demographic and clinical data were extracted from records. Survival was assessed using Kaplan-Meier analysis, and predictors of mortality were evaluated using Cox proportional hazards regression. Results: Of the 158 patients enrolled, 152 met inclusion criteria. Over a 122-week follow-up, 48 (31.5%) patients died and 104 survived. The overall mean survival was 108 ± 2 weeks. Multivariable Cox regression identified increasing age (HR = 1.04, p<0.001), body weight (HR = 1.03, p=0.015), and underweight status (HR = 1.93, p=0.034) as independent risk factors for mortality. Conversely, higher body mass index (BMI) (HR = 0.80, p<0.001) and serum albumin (HR = 0.52, p=0.036) were protective. Conclusion: Survival in hemodialysis patients is significantly influenced by age, nutritional status, and albumin levels. These findings support the implementation of routine nutritional assessments and targeted interventions to reduce mortality. Future studies should explore broader determinants in multicenter prospective cohorts to improve long-term outcomes for ESRD patients in resource-limited settings.

Downloads

Download data is not yet available.

References

Ali Jaffar Naqvi, S. (2000). Nephrology services in Pakistan. Nephrology Dialysis Transplantation, 15(6), 769-771.

https://doi.org/10.1093/ndt/15.6.769

Anees, M., Batool, S., Imtiaz, M., & Ibrahim, M. (2018). Socio-economic factors affecting quality of life of hemodialysis patients and its effects on mortality. Pakistan Journal of Medical Sciences, 34(4).

https://doi.org/10.12669/pjms.344.15284

Bae, E. H., Oh, T. R., Suh, S. H., Yang, E. M., Choi, H. S., Kim, C. S., Ma, S. K., Kim, B., Han, K., & Kim, S. W. (2021). Underweight and weight change increases end-stage renal disease risk in patients with diabetes: A nationwide population-based cohort study. Nutrients, 14(1), 154.

https://doi.org/10.3390/nu14010154

Bukhari, H., Ahmad, A., Noorin, A., Khan, A., Mushtaq, M., Naeem, A., Iqbal, M. R., Naureen, F., Shah, Y., Qayyum, A., Munib, S., Azhar, A., Ullah, F., & Khan, F. F. (2023). Association of anemia with parathyroid hormone levels and other factors in patients with end-stage renal disease undergoing hemodialysis: A cross-sectional, real-world data study in Pakistan. International Journal of Clinical Practice, 2023, 1-12.

https://doi.org/10.1155/2023/7418857

Collins, A. J., Foley, R. N., Herzog, C., Chavers, B. M., Gilbertson, D., Ishani, A., Kasiske, B. L., Liu, J., Mau, L., & McBean, M. (2010). Excerpts from the US renal data system 2009 annual data report. American Journal of Kidney Diseases, 55(1), A6-A7.

https://doi.org/10.1053/j.ajkd.2009.10.009

Jha, V., Wang, A. Y., & Wang, H. (2012). The impact of CKD identification in large countries: The burden of illness. Nephrology Dialysis Transplantation, 27(suppl 3), iii32-iii38.

https://doi.org/10.1093/ndt/gfs113

Johansen, K. L., Chertow, G. M., Gilbertson, D. T., Ishani, A., Israni, A., Ku, E., Li, S., Li, S., Liu, J., Obrador, G. T., Schulman, I., Chan, K., Abbott, K. C., O’Hare, A. M., Powe, N. R., Roetker, N. S., Scherer, J. S., St. Peter, W., Snyder, J., … Wetmore, J. B. (2023). US renal data system 2022 annual data report: Epidemiology of kidney disease in the United States. American Journal of Kidney Diseases, 81(3), A8-A11.

https://doi.org/10.1053/j.ajkd.2022.12.001

Kalantar-Zadeh, K., Ikizler, T., Block, G., Avram, M. M., & Kopple, J. D. (2003). Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. American Journal of Kidney Diseases, 42(5), 864-881.

https://doi.org/10.1016/j.ajkd.2003.07.016

Khan, M. U., Ibrahim, M. M., & Butt, A. A. (2020). Hepatitis c virus and chronic kidney disease. Expert Review of Gastroenterology & Hepatology, 14(7), 579-590.

https://doi.org/10.1080/17474124.2020.1776111

Kher, V. (2002). End-stage renal disease in developing countries. Kidney International, 62(1), 350-362.

https://doi.org/10.1046/j.1523-1755.2002.00426.x

Kikuchi, H., Kanda, E., Mandai, S., Akazawa, M., Iimori, S., Oi, K., Naito, S., Noda, Y., Toda, T., Tamura, T., Sasaki, S., Sohara, E., Okado, T., Rai, T., & Uchida, S. (2017). Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study. Clinical and Experimental Nephrology, 21(1), 55-62.

https://doi.org/10.1007/s10157-016-1251-2

Kim, C. S., Oh, T. R., Suh, S. H., Choi, H. S., Bae, E. H., Ma, S. K., Kim, B., Han, K.-D., & Kim, S. W. (2023). Underweight status

and development of end-stage kidney disease: A nationwide population-based study. Journal of Cachexia, Sarcopenia and Muscle, 14(5), 2184-2195.

https://doi.org/https://doi.org/10.1002/jcsm.13297

Leavey, S. F., McCullough, K., Hecking, E., Goodkin, D., Port, F. K., & Young, E. W. (2001). Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation, 16(12), 2386-2394.

https://doi.org/10.1093/ndt/16.12.2386

Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H. M., Okpechi, I., Zhao, M. H., Lv, J., Garg, A. X., Knight, J., Rodgers, A., Gallagher, M., Kotwal, S., Cass, A., & Perkovic, V. (2015). Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet, 385(9981), 1975-1982.

https://doi.org/10.1016/s0140-6736(14)61601-9

Locatelli, F., Aljama, P., Bárány, P., Canaud, B., Carrera, F., Eckardt, K. U., Hörl, W. H., Macdougal, I. C., Macleod, A., Wiecek, A., & Cameron, S. (2004). Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant, 19 Suppl 2, ii1-47.

https://doi.org/10.1093/ndt/gfh1032

Locatelli, F., Bárány, P., Covic, A., De Francisco, A., Del Vecchio, L., Goldsmith, D., Hörl, W., London, G., Vanholder, R., Van Biesen, W., Board, o. b. o. t. E.-E. E. A., Abramovicz, D., Cannata-Andia, J., Cochat, P., Eckardt, K. U., Fouque, D., Heimburger, O., Jäger, K., Jenkins, S., . . . Wanner, C. (2013). Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrology Dialysis Transplantation, 28(6), 1346-1359.

https://doi.org/10.1093/ndt/gft033

Palmer, S. C. (2010). Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease. Annals of Internal Medicine, 153(1), 23.

https://doi.org/10.7326/0003-4819-153-1-201007060-00252

Naqvi, S. J. (2009). Renal diseases in Pakistan-‘time to act.’. J Nephrol Renal Transplant, 2(1), 133-35.

Naseem, A., Rafique, Z., Rehman, H. S., & Asrar, A. (2019). Socioeconomic Status of Maintenance Hemodialysis Patients from a Tertiary Care Hospital in Lahore. Pakistan Journal of Kidney Diseases, 3(10).

https://doi.org/10.53778/pjkd31093

Ouyang, Y., Xie, J., Yang, M., Zhang, X., Ren, H., Wang, W., & Chen, N. (2016). Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy. PLOS ONE, 11(9), e0162044.

https://doi.org/10.1371/journal.pone.0162044

Rao, A., Evans, R., Wilkie, M., Fluck, R., & Kumwenda, M. (2016). UK renal registry 18th annual report: Chapter 11 2014 multisite dialysis access audit in England, Northern Ireland and Wales and 2013 PD one year follow-up: National and centre-specific analyses. Nephron, 132(1), 253-278.

https://doi.org/10.1159/000444825

Rao, M. (1998). Haemodialysis for end-stage renal disease in southern India - a perspective from a tertiary referral care centre. Nephrology Dialysis Transplantation, 13(10), 2494-2500.

https://doi.org/10.1093/ndt/13.10.2494

Robinson, B. M., Akizawa, T., Jager, K. J., Kerr, P. G., Saran, R., & Pisoni, R. L. (2016). Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: Differences in access to renal replacement therapy, modality use, and haemodialysis practices. The Lancet, 388(10041), 294-306.

https://doi.org/10.1016/s0140-6736(16)30448-2